Peanut

Washington Trust Kicks Off 24th Annual Peanut Butter Drive to Benefit Local Food Banks

Retrieved on: 
Monday, March 11, 2024
Washington Trust Bank, Friends, Food bank, Hunger, Drive, Feeding America, Risk, Bank, Greater Boston Food Bank, Food, Peanut, Collection

WESTERLY, R.I., March 11, 2024 /PRNewswire/ -- The Washington Trust Company ("Washington Trust," "the Bank") today announced the Bank has kicked off its 24th annual Peanut Butter Drive and will collect jars of peanut butter at the Bank's 27 branch locations through March 31, 2024.

Key Points: 
  • WESTERLY, R.I., March 11, 2024 /PRNewswire/ -- The Washington Trust Company ("Washington Trust," "the Bank") today announced the Bank has kicked off its 24th annual Peanut Butter Drive and will collect jars of peanut butter at the Bank's 27 branch locations through March 31, 2024.
  • Peanut butter collected from the Washington Trust Peanut Butter Drive is donated to 19 local hunger relief agencies across the Bank's footprint, and online contributions support the Rhode Island Community Food Bank, Connecticut Foodshare , and the Greater Boston Food Bank .
  • "Washington Trust started the Peanut Butter Drive 24 years ago and, since that time, we've collected 159 tons of peanut butter— enough to make 5 million peanut butter sandwiches," said Edward O.
  • Drop off a jar of peanut butter at any Washington Trust branch location .

Intrommune Therapeutics Presents Supporting Data Introducing a New Form of Food Allergy Treatment

Retrieved on: 
Thursday, February 22, 2024
AAAAI, Food allergy, MD, Ara, Physician, Food, Immunoglobulin E, H2, Therapy, Patient, Immunoglobulin G, Asthma, Peanut, Research, American Academy, Pharmaceutical industry

NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, announces data in a late-breaking poster presentation at this year’s American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting in Washington, D.C. supporting Oral Mucosal Immunotherapy (OMIT) as a potential new form of food allergy treatment.

Key Points: 
  • NEW YORK, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, announces data in a late-breaking poster presentation at this year’s American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting in Washington, D.C. supporting Oral Mucosal Immunotherapy (OMIT) as a potential new form of food allergy treatment.
  • This data demonstrates that OMIT, an investigational treatment, which delivers allergenic proteins utilizing an innovative, specially formulated toothpaste, can safely be used to treat patients with food allergies in a more convenient way than food allergy therapies currently available.
  • The results of this study suggest OMIT as a new approach for the management of food allergy, providing a strong foundation for further research in the pediatric population.
  • The addition of OMIT as a new, safe and convenient option for both patients and physicians, marks an important advancement in the treatment of food allergies.

Catalina Crunch® Appoints Three New Key Members To Its Growing Leadership Team

Retrieved on: 
Monday, March 4, 2024
Dark, Peanut, Senior, Danone North America, NBA, SVP, Record, Morningstar Farms, Nature, Eggo, Snack, Starbucks, KIND, National accounts, AJ, Partnership

INDIANAPOLIS, March 4, 2024 /PRNewswire/ -- Catalina Crunch®, the pioneering brand in healthier snacks, is excited to unveil the latest additions to its leadership team. The company proudly welcomes Lauri Luker as the Chief Operating Officer, Jim Duddleston as Senior Vice President of National Accounts and West, and Kristy Vigil as Senior Vice President of Natural Channel and East. In their strategic roles, Lauri, Jim, and Kristy will be instrumental in steering Catalina Crunch® into its next phase of robust growth, strategically expanding the brand's retail presence. This significant announcement not only underscores the brand's dedication to meeting the soaring demand for its products but also highlights Catalina Crunch®'s ongoing commitment to fortifying and expanding its executive team.

Key Points: 
  • INDIANAPOLIS, March 4, 2024 /PRNewswire/ -- Catalina Crunch ®, the pioneering brand in healthier snacks, is excited to unveil the latest additions to its leadership team.
  • "We are thrilled to welcome Lauri, Jim, and Kristy to the Catalina Crunch® family.
  • The trio of Lauri Luker, Jim Duddleston, and Kristy Vigil brings a wealth of experience and industry acumen to Catalina Crunch®.
  • For more information on Catalina Crunch® visit us.catalinacrunch.com and follow on Instagram ( @CatalinaCrunch ), Facebook ( @CatalinaCrunch ) and TikTok ( @CatalinaCrunch ).

Viral Sensation: Jar Joy's Peanut Butter Cup Jars Sweep Through Costco, Hitting 5 Million Views on TikTok and Instagram in 48 Hours

Retrieved on: 
Thursday, February 22, 2024
Taste, Peanut butter cup, Peanut, Collection, Internet, NBC, Amusement park

Echoing the viral success of Costco's peanut butter chocolate pie last year, which was featured on NBC's today.com and other major media outlets, Jar Joy's Peanut Butter Cup jars have set the internet on fire with their deliciously layered dessert that perfectly blends rich peanut butter with luscious chocolate.

Key Points: 
  • Echoing the viral success of Costco's peanut butter chocolate pie last year, which was featured on NBC's today.com and other major media outlets, Jar Joy's Peanut Butter Cup jars have set the internet on fire with their deliciously layered dessert that perfectly blends rich peanut butter with luscious chocolate.
  • "We couldn't be more thrilled with the viral success of our Peanut Butter Cup jars at Costco," said Shaun Hunte, the company's CEO and Founder at Jar Joy.
  • The Peanut Butter Cup jars are the latest gem in Jar Joy's esteemed collection of single-serve dessert jars, which aim to provide a premium dessert experience in a convenient portable format.
  • Each jar showcases Jar Joy's commitment to excellence, crafted with top-quality ingredients for an unparalleled taste.

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

Retrieved on: 
Wednesday, February 21, 2024
Acquisition, Messenger, DSM-IV codes, FRA, Vaccine, IMV, CAD, Peanut, Infection, Partnership

At the closing, BioVaxys delivered to HIMV a one-time payment of both US$750,000 in cash and 5,034,701 common shares of BioVaxys at a deemed price of CAD$0.067.

Key Points: 
  • At the closing, BioVaxys delivered to HIMV a one-time payment of both US$750,000 in cash and 5,034,701 common shares of BioVaxys at a deemed price of CAD$0.067.
  • With the transaction now complete, BioVaxys is working on integrating the acquired assets into the Company.
  • BioVaxys President and Chief Operating Officer Kenneth Kovan stated "We now have massive opportunities in oncology, infectious disease, allergy desensitization, and autoimmune diseases.
  • We will be identifying target partners where our solutions can address specific needs or gaps, making BioVaxys an attractive 'go-to' partner for targeted immunotherapies."

BIOVAXYS COMPLETES THE ACQUISITION OF ALL INTELLECTUAL PROPERTY, IMMUNOTHERAPEUTICS PLATFORM TECHNOLOGY, AND CLINICAL STAGE ASSETS OF THE FORMER IMV INC.

Retrieved on: 
Wednesday, February 21, 2024
Acquisition, Messenger, DSM-IV codes, FRA, Vaccine, IMV, CAD, Peanut, Infection, Partnership

At the closing, BioVaxys delivered to HIMV a one-time payment of both US$750,000 in cash and 5,034,701 common shares of BioVaxys at a deemed price of CAD$0.067.

Key Points: 
  • At the closing, BioVaxys delivered to HIMV a one-time payment of both US$750,000 in cash and 5,034,701 common shares of BioVaxys at a deemed price of CAD$0.067.
  • With the transaction now complete, BioVaxys is working on integrating the acquired assets into the Company.
  • BioVaxys President and Chief Operating Officer Kenneth Kovan stated "We now have massive opportunities in oncology, infectious disease, allergy desensitization, and autoimmune diseases.
  • We will be identifying target partners where our solutions can address specific needs or gaps, making BioVaxys an attractive 'go-to' partner for targeted immunotherapies."

FDA Approves First Medication to Help Reduce Allergic Reactions to Multiple Foods After Accidental Exposure

Retrieved on: 
Friday, February 16, 2024
Human services, Allergy, Fever, Division, Research, Food allergy, Polyp (medicine), Sinusitis, Hazelnut, Cosmetics, Multimedia, Hypersensitivity, Dietary supplement, Critical care, FDA, Food, Immunoglobulin E, Infection, Asthma, Anaphylaxis, Peanut allergy, Skin, Vomiting, Emergency, Vaccine, Risk, Animal, Safety, Heated tobacco product, Arthralgia, History, Milk, Malignancy, Rash, Public, Patient, Adrenaline, Peanut, Priority review

Xolair is intended for repeated use to reduce the risk of allergic reactions and is not approved for the immediate emergency treatment of allergic reactions, including anaphylaxis.

Key Points: 
  • Xolair is intended for repeated use to reduce the risk of allergic reactions and is not approved for the immediate emergency treatment of allergic reactions, including anaphylaxis.
  • "While it will not eliminate food allergies or allow patients to consume food allergens freely, its repeated use will help reduce the health impact if accidental exposure occurs."
  • Current treatment requires strict avoidance of the food(s) the patient is allergic to, and prompt administration of epinephrine to treat anaphylaxis should accidental exposures occur.
  • Xolair is the first FDA-approved medication to reduce allergic reactions to more than one type of food after accidental exposure.

Herbal medicinal product: Soiae oleum raffinatumArray, D: Draft under discussion

Retrieved on: 
Saturday, February 10, 2024
Peanut, Plant, Pea, Pollen, Allergy, Rash, Inflammation, Date, Infection, Committee, Heart, Monograph, Keratitis, Herbal medicine, Eye, Patient, Bath, Medicine, Accidental, Skin, Medicinal plants

Overview

Key Points: 
  • Overview
    This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of soya-bean oil.
  • The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing soya-bean oil.
  • Soya-bean oil may also be found in combination with other herbal substances in some herbal medicines.
  • Key facts
    - Latin name
    - Soiae oleum raffinatum
    - English common name
    - Soya-bean oil
    - Botanical name
    Glycine max (L.) Merr., oleum
    - Therapeutic area
    - Skin disorders and minor wounds
    - Status
    - D: Draft under discussion
    - Date added to the inventory
    - Date added to priority list
    - Outcome of European assessment
    - European Union herbal monograph

MARS RELEASES STAR-STUDDED M&M'S® "ALMOST CHAMPIONS" SUPER BOWL LVIII AD FEATURING SCARLETT JOHANSSON CAMEO

Retrieved on: 
Tuesday, February 6, 2024
M&M, Leg, Life, Clothing, Peanut butter, Collection, News, Super Bowl, Humour, Ecosystem, Big Game, Happiness, Love, CBS, Peanut, Comfort, NFL

NEWARK, N.J., Feb. 6, 2024 /PRNewswire/ -- Today, M&M'S®, proudly part of the Mars family of brands, has released its Super Bowl LVIII ad, "Almost Champions," revealing acclaimed actress Scarlett Johansson starring alongside Dan Marino, Terrell Owens and Bruce Smith. In the spot, Johansson and the trio of NFL Legends are shown in a lab with the beloved M&M'S characters admiring the first-of-its-kind "M&M'S Almost Champions Ring of Comfort," while having a self-effacing laugh about the feeling of being "almost champions." Each of these incredibly talented superstars came together with one of the world's biggest brands to humbly relate to finishing as the runner-up in their respective Oscar® nominations and Super Bowl appearances.  The ad uses M&M'S signature humor and leans into M&M'S purpose of using the power of fun to create a world where everyone feels they belong, bringing this star-studded group together in a way only M&M'S can.

Key Points: 
  • NEWARK, N.J., Feb. 6, 2024 /PRNewswire/ -- Today, M&M'S®, proudly part of the Mars family of brands, has released its Super Bowl LVIII ad, " Almost Champions ," revealing acclaimed actress Scarlett Johansson starring alongside Dan Marino, Terrell Owens and Bruce Smith.
  • The innovative ring upends the long-standing sports tradition that only the winning team walks away with a Super Bowl ring.
  • "My favorite thing about Mars' M&M'S Super Bowl campaign is the encouragement to have fun and a sense of humor, whether you're a winner or not," said Scarlett Johansson of her appearance in the spot.
  • "It's playful and comforting at the same time, just like one of my all-time favorite Mars candies, Peanut Butter M&M'S.

Ole Smoky Distillery Earns Coveted Distillery of the Year Title in the 2023 PR%F Awards

Retrieved on: 
Tuesday, January 23, 2024
Retail, Restaurant, Bar, Food, Beverage, Wine & Spirits, Cream, Distillation, Delta Air Lines, Multimedia, PR, Peanut, Ole Smoky Distillery, Butter, Magazine, Century, Liquor

Ole Smoky Distillery , one of the nation’s fastest growing spirits companies and the most visited distillery in the world, has been honored as Distillery of the Year in the 2023 PR%F Awards , one of the most sought-after awards in the annual competition.

Key Points: 
  • Ole Smoky Distillery , one of the nation’s fastest growing spirits companies and the most visited distillery in the world, has been honored as Distillery of the Year in the 2023 PR%F Awards , one of the most sought-after awards in the annual competition.
  • View the full release here: https://www.businesswire.com/news/home/20240123713664/en/
    The coveted Distillery of the Year award is determined by the collective scores of each entered product, considering its originality, consistency, flavor diversity, taste components, and packaging.
  • "Receiving PR%F the Magazine’s Distillery of the Year Award is a true testament to the passion, dedication, and relentless pursuit of excellence from the Ole Smoky team,” said Robert Hall, CEO, Ole Smoky Distillery.
  • Ole Smoky Moonshine and Whiskey can be found in all 50 states and over 20 countries around the world where liquor is sold.